Mercer Global Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
+8,963
New +$323K ﹤0.01% 2835
2025
Q2
Sell
-3,456
Closed -$209K 2280
2025
Q1
$209K Buy
3,456
+366
+12% +$23.6K ﹤0.01% 1952
2024
Q4
$211K Sell
3,090
-1,080
-26% -$75.3K ﹤0.01% 1946
2024
Q3
$285K Sell
4,170
-253
-6% -$17.9K ﹤0.01% 1637
2024
Q2
$307K Buy
4,423
+119
+3% +$8.68K ﹤0.01% 1563
2024
Q1
$345K Sell
4,304
-446
-9% -$39.8K ﹤0.01% 1487
2023
Q4
$520K Buy
4,750
+461
+11% +$47.7K ﹤0.01% 1307
2023
Q3
$433K Buy
4,289
+710
+20% +$81.6K ﹤0.01% 1321
2023
Q2
$486K Sell
3,579
-68
-2% -$8.3K ﹤0.01% 1245
2023
Q1
$379K Sell
3,647
-182
-5% -$17.6K ﹤0.01% 1359
2022
Q4
$339K Sell
3,829
-328
-8% -$27.2K ﹤0.01% 1436
2022
Q3
$333K Sell
4,157
-112
-3% -$10.6K ﹤0.01% 1346
2022
Q2
$409K Sell
4,269
-260
-6% -$31.2K ﹤0.01% 1246
2022
Q1
$673K Sell
4,529
-328
-7% -$45.8K ﹤0.01% 1082
2021
Q4
$689K Buy
4,857
+62
+1% +$8.78K ﹤0.01% 1065
2021
Q3
$627K Sell
4,795
-170
-3% -$22.2K ﹤0.01% 1062
2021
Q2
$682K Sell
4,965
-264
-5% -$36.1K 0.01% 1006
2021
Q1
$683K Sell
5,229
-422
-7% -$50.8K 0.01% 941
2020
Q4
$633K Sell
5,651
-925
-14% -$87.6K 0.01% 779
2020
Q3
$517K Sell
6,576
-9,616
-59% -$784K 0.01% 768
2020
Q2
$1.17M Buy
16,192
+2,009
+14% +$140K 0.02% 454
2020
Q1
$812K Sell
14,183
-674
-5% -$62.2K 0.02% 537
2019
Q4
$1.66M Buy
14,857
+2,210
+17% +$236K 0.03% 385
2019
Q3
$1.22M Buy
12,647
+386
+3% +$36.2K 0.03% 425
2019
Q2
$1.05M Buy
12,261
+202
+2% +$16.6K 0.03% 449
2019
Q1
$1M Buy
+12,059
New +$876K 0.04% 413

Other funds holding CNMD

Mercer Global Advisors's CNMD Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in CONMED (CNMD) in Q2 2026: 8,963 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #2835 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in CNMD as recently as Q1 2025.

Mercer Global Advisors first reported a position in CNMD in Q1 2019 and has held it in 26 quarters since. The position peaked at $1.66M in Q4 2019. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Mercer Global Advisors held 8,963 shares of CONMED worth $293K as of Q2 2026.
  • CONMED was a new Mercer Global Advisors position in Q2 2026.
  • CONMED made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2835 holding.
  • Mercer Global Advisors first reported a position in CONMED in Q1 2019 and has held it in 26 quarters since.
  • Mercer Global Advisors's CONMED position peaked at $1.66M in Q4 2019.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.